- Glutamate and GABA concentrations in the cerebellum of novel ataxic mutant Pogo mice
-
Kim KH, Ha JH, Chung SH, Kim CT, Kim SK, Hyun BH, Sawada K, Fukui Y, Park IK, Lee GJ, Kim BK, Lee NS, Jeong YG
- KMID: 1089599
- J Vet Sci.
- 2003 Dec;4(3):209-212.
The Pogo mouse is an autosomal recessive ataxic mutant that arose spontaneously in the inbred KJR/MsKist strain derived originally from Korean wild mice. The ataxic phenotype is characterized by difficulty... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunohistochemistry of Voltage-Gated Calcium Channel alpha1B Subunit in Mouse Cerebellum
-
Chung SH, Lee KY, Kim KH, Kim CT, Lee NS, Sawada K, Haga H, Lee BC, Fukui Y, Rhee MH, Jeong YG
- KMID: 1095118
- J Vet Sci.
- 2002 Sep;3(3):175-178.
Secretion of neurotransmitters is initiated by voltagegated calcium influx through presynaptic, voltage- gated N-type calcium channels. However, little is known about their cellular distribution in the mouse cerebellum. In the... -
- CITED
-
- Close
- SHARE
-
- Close
- Differences of Zebrin II Expression Pattern Between Normal Balb/C and Ataxic Pogo Mouse Cerebellum
-
Lee NS, Kim CT, Kim KH, Kim SK, Chung SH, Ko KO, Sawada K, Fukui Y, Hyun BW, Won MH, Jeong YG
- KMID: 2224512
- Korean J Anat.
- 2003 Dec;36(6):457-462.
The purpose of this study is to identify the differences of zebrin II expression between ataxic pogo and normal Balb/C mouse cerebellum. Zebrin II is expressed by subsets of Purkinje... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
-
Shimura K, Mabuchi S, Yokoi T, Sasano T, Sawada K, Hamasaki T, Kimura T
- KMID: 2177873
- J Gynecol Oncol.
- 2013 Oct;24(4):321-329.
- doi: 10.3802/jgo.2013.24.4.321
OBJECTIVE: To investigate the utility of serum squamous cell carcinoma antigen (SCC-Ag) levels upon the diagnosis of recurrent cervical cancer for decision making in patient management. METHODS: Clinical records from 167... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of Bolus 5-Fluorouracil and L-Leucovorin as Salvage Chemotherapy for Oral Fluoropyrimidine-Resistant Unresectable or Recurrent Gastric Cancer: A Single Center Experience
-
Muranaka T, Yuki S, Komatsu Y, Sawada K, Harada K, Kawamoto Y, Nakatsumi , Sakamoto N
- KMID: 2372561
- J Gastric Cancer.
- 2016 Sep;16(3):177-181.
- doi: 10.5230/jgc.2016.16.3.177
PURPOSE: The International Organization for Standardization-5fluorouracil (FU) 10 trial found that bolus 5-FU and l-leucovorin was not inferior to S-1 in the treatment of gastric cancer (GC). Continuous 5-FU and... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study
-
Iwaki M, Fujii H, Hayashi H, Toyoda H, Oeda S, Hyogo H, Kawanaka M, Morishita A, Munekage K, Kawata K, Tsutsumi T, Sawada K, Maeshiro T, Tobita H, Yoshida Y, Naito M, Araki A, Arakaki S, Kawaguchi T, Noritake H, Ono M, Masaki T, Yasuda S, Tomita E, Yoneda M, Tokushige A, Kamada Y, Takahashi H, Ueda S, Aishima S, Sumida Y, Nakajima A, Okanoue T, Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
- KMID: 2554428
- Clin Mol Hepatol.
- 2024 Apr;30(2):225-234.
- doi: 10.3350/cmh.2023.0515
Background/Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) was recently proposed as an alternative disease concept to nonalcoholic fatty liver disease (NAFLD). We aimed to investigate the prognosis of patients with... -
- CITED
-
- Close
- SHARE
-
- Close
